Sökning: onr:"swepub:oai:lup.lub.lu.se:9d0f7aa7-4b47-4171-aa8d-b0038691ec57" >
Somatic Mutations i...
Somatic Mutations in Exocrine Pancreatic Tumors: Association with Patient Survival
-
Rachakonda, P. Sivaramakrishna (författare)
-
Bauer, Andrea S. (författare)
-
Xie, Huaping (författare)
-
visa fler...
-
Campa, Daniele (författare)
-
Rizzato, Cosmeri (författare)
-
Canzian, Federico (författare)
-
Beghelli, Stefania (författare)
-
Greenhalf, William (författare)
-
Costello, Eithne (författare)
-
Schanne, Michaela (författare)
-
Heller, Anette (författare)
-
Scarpa, Aldo (författare)
-
Neoptolemos, John P. (författare)
-
Werner, Jens (författare)
-
Buechler, Markus (författare)
-
Hoheisel, Joerg D. (författare)
-
- Hemminki, Kari (författare)
- Lund University,Lunds universitet,Allmänmedicin och klinisk epidemiologi,Forskargrupper vid Lunds universitet,Family Medicine and Clinical Epidemiology,Lund University Research Groups
-
Giese, Nathalia (författare)
-
Kumar, Rajiv (författare)
-
visa färre...
-
(creator_code:org_t)
- 2013-04-02
- 2013
- Engelska.
-
Ingår i: PLoS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 8:4
- Relaterad länk:
-
https://portal.resea... (primary) (free)
-
visa fler...
-
http://dx.doi.org/10... (free)
-
https://journals.plo...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- KRAS mutations are major factors involved in initiation and maintenance of pancreatic tumors. The impact of different mutations on patient survival has not been clearly defined. We screened tumors from 171 pancreatic cancer patients for mutations in KRAS and CDKN2A genes. Mutations in KRAS were detected in 134 tumors, with 131 in codon 12 and only 3 in codon 61. The GGT>GAT (G12D) was the most frequent mutation and was present in 60% (80/134). Deletions and mutations in CDKN2A were detected in 43 tumors. Analysis showed that KRAS mutations were associated with reduced patient survival in both malignant exocrine and ductal adenocarcinomas (PDAC). Patients with PDACs that had KRAS mutations showed a median survival of 17 months compared to 30 months for those without mutations (log-rank P = 0.07) with a multivariate hazard ratio (HR) of 2.19 (95% CI 1.09-4.42). The patients with G12D mutation showed a median survival of 16 months (log-rank-test P = 0.03) and an associated multivariate HR 2.42 (95% CI 1.14-2.67). Although, the association of survival in PDAC patients with CDKN2A aberrations in tumors was not statistically significant, the sub-group of patients with concomitant KRAS mutations and CDKN2A alterations in tumors were associated with a median survival of 13.5 months compared to 22 months without mutation (log-rank-test P = 0.02) and a corresponding HR of 3.07 (95% CI 1.33-7.10). Our results are indicative of an association between mutational status and survival in PDAC patients, which if confirmed in subsequent studies can have potential clinical application.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap -- Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Health Sciences -- Public Health, Global Health, Social Medicine and Epidemiology (hsv//eng)
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
-
PLoS ONE
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas
- Av författaren/redakt...
-
Rachakonda, P. S ...
-
Bauer, Andrea S.
-
Xie, Huaping
-
Campa, Daniele
-
Rizzato, Cosmeri
-
Canzian, Federic ...
-
visa fler...
-
Beghelli, Stefan ...
-
Greenhalf, Willi ...
-
Costello, Eithne
-
Schanne, Michael ...
-
Heller, Anette
-
Scarpa, Aldo
-
Neoptolemos, Joh ...
-
Werner, Jens
-
Buechler, Markus
-
Hoheisel, Joerg ...
-
Hemminki, Kari
-
Giese, Nathalia
-
Kumar, Rajiv
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Hälsovetenskap
-
och Folkhälsovetensk ...
- Artiklar i publikationen
-
PLoS ONE
- Av lärosätet
-
Lunds universitet